From Food Map to FODMAP in Irritable Bowel Sindrome.

Antonio Carroccio, Pasquale Mansueto, Antonio Carroccio, Alberto D'Alcamo, Aurelio Seidita

Risultato della ricerca: Chapter

Abstract

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases in the general population, with a prevalence ranging from 12 % to 30 %, mainly affecting younger patients (i.e., <50 years of age) and women [1]. As in other chronic functional gastrointestinal disorders, abdominal discomfort or pain, abnormal bowel habits, and often bloating and abdominal distension are the main clinical features. Their diagnosis is based on symptom patterns (i.e., the Rome III criteria), which also allow categorization in diarrhea-predominant (D-IBS), constipation-predominant (C-IBS), mixed diarrhea and constipation (M-IBS), and unclassified (U-IBS) IBS [2]. Symptom severity ranges from tolerable to severe, both between different patients and in the same patient, affecting patients’ quality of life considerably as in some major chronic diseases [3]. Depending on whether diarrhea or constipation is the predominant disorder, antispasmodics, antidepressants, and medications modifying bowel habit represent the main conventional IBS treatments. Unfortunately, most patients report long-term inadequacy of current drug therapy and a tendency to seek a variety of alternative remedies, especially of a dietary nature (up to 65 % of them attribute their symptoms to adverse food reactions) [4]. However, the relationship between IBS symptoms and diet is still controversial, because of research quality and low number of scientific studies [5]. This represents a glaring gap that needs to be addressed.
Lingua originaleEnglish
Titolo della pubblicazione ospiteHuman Nutrition from the Gastroenterologist’s Perspective
Pagine139-167
Numero di pagine29
Stato di pubblicazionePublished - 2016

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cita questo

Carroccio, A., Mansueto, P., Carroccio, A., D'Alcamo, A., & Seidita, A. (2016). From Food Map to FODMAP in Irritable Bowel Sindrome. In Human Nutrition from the Gastroenterologist’s Perspective (pagg. 139-167)

From Food Map to FODMAP in Irritable Bowel Sindrome. / Carroccio, Antonio; Mansueto, Pasquale; Carroccio, Antonio; D'Alcamo, Alberto; Seidita, Aurelio.

Human Nutrition from the Gastroenterologist’s Perspective. 2016. pag. 139-167.

Risultato della ricerca: Chapter

Carroccio, A, Mansueto, P, Carroccio, A, D'Alcamo, A & Seidita, A 2016, From Food Map to FODMAP in Irritable Bowel Sindrome. in Human Nutrition from the Gastroenterologist’s Perspective. pagg. 139-167.
Carroccio A, Mansueto P, Carroccio A, D'Alcamo A, Seidita A. From Food Map to FODMAP in Irritable Bowel Sindrome. In Human Nutrition from the Gastroenterologist’s Perspective. 2016. pag. 139-167
Carroccio, Antonio ; Mansueto, Pasquale ; Carroccio, Antonio ; D'Alcamo, Alberto ; Seidita, Aurelio. / From Food Map to FODMAP in Irritable Bowel Sindrome. Human Nutrition from the Gastroenterologist’s Perspective. 2016. pagg. 139-167
@inbook{7ea0371fca094bf7986aa8b867f78177,
title = "From Food Map to FODMAP in Irritable Bowel Sindrome.",
abstract = "Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases in the general population, with a prevalence ranging from 12 {\%} to 30 {\%}, mainly affecting younger patients (i.e., <50 years of age) and women [1]. As in other chronic functional gastrointestinal disorders, abdominal discomfort or pain, abnormal bowel habits, and often bloating and abdominal distension are the main clinical features. Their diagnosis is based on symptom patterns (i.e., the Rome III criteria), which also allow categorization in diarrhea-predominant (D-IBS), constipation-predominant (C-IBS), mixed diarrhea and constipation (M-IBS), and unclassified (U-IBS) IBS [2]. Symptom severity ranges from tolerable to severe, both between different patients and in the same patient, affecting patients’ quality of life considerably as in some major chronic diseases [3]. Depending on whether diarrhea or constipation is the predominant disorder, antispasmodics, antidepressants, and medications modifying bowel habit represent the main conventional IBS treatments. Unfortunately, most patients report long-term inadequacy of current drug therapy and a tendency to seek a variety of alternative remedies, especially of a dietary nature (up to 65 {\%} of them attribute their symptoms to adverse food reactions) [4]. However, the relationship between IBS symptoms and diet is still controversial, because of research quality and low number of scientific studies [5]. This represents a glaring gap that needs to be addressed.",
author = "Antonio Carroccio and Pasquale Mansueto and Antonio Carroccio and Alberto D'Alcamo and Aurelio Seidita",
year = "2016",
language = "English",
isbn = "978-3-319-30359-8",
pages = "139--167",
booktitle = "Human Nutrition from the Gastroenterologist’s Perspective",

}

TY - CHAP

T1 - From Food Map to FODMAP in Irritable Bowel Sindrome.

AU - Carroccio, Antonio

AU - Mansueto, Pasquale

AU - Carroccio, Antonio

AU - D'Alcamo, Alberto

AU - Seidita, Aurelio

PY - 2016

Y1 - 2016

N2 - Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases in the general population, with a prevalence ranging from 12 % to 30 %, mainly affecting younger patients (i.e., <50 years of age) and women [1]. As in other chronic functional gastrointestinal disorders, abdominal discomfort or pain, abnormal bowel habits, and often bloating and abdominal distension are the main clinical features. Their diagnosis is based on symptom patterns (i.e., the Rome III criteria), which also allow categorization in diarrhea-predominant (D-IBS), constipation-predominant (C-IBS), mixed diarrhea and constipation (M-IBS), and unclassified (U-IBS) IBS [2]. Symptom severity ranges from tolerable to severe, both between different patients and in the same patient, affecting patients’ quality of life considerably as in some major chronic diseases [3]. Depending on whether diarrhea or constipation is the predominant disorder, antispasmodics, antidepressants, and medications modifying bowel habit represent the main conventional IBS treatments. Unfortunately, most patients report long-term inadequacy of current drug therapy and a tendency to seek a variety of alternative remedies, especially of a dietary nature (up to 65 % of them attribute their symptoms to adverse food reactions) [4]. However, the relationship between IBS symptoms and diet is still controversial, because of research quality and low number of scientific studies [5]. This represents a glaring gap that needs to be addressed.

AB - Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases in the general population, with a prevalence ranging from 12 % to 30 %, mainly affecting younger patients (i.e., <50 years of age) and women [1]. As in other chronic functional gastrointestinal disorders, abdominal discomfort or pain, abnormal bowel habits, and often bloating and abdominal distension are the main clinical features. Their diagnosis is based on symptom patterns (i.e., the Rome III criteria), which also allow categorization in diarrhea-predominant (D-IBS), constipation-predominant (C-IBS), mixed diarrhea and constipation (M-IBS), and unclassified (U-IBS) IBS [2]. Symptom severity ranges from tolerable to severe, both between different patients and in the same patient, affecting patients’ quality of life considerably as in some major chronic diseases [3]. Depending on whether diarrhea or constipation is the predominant disorder, antispasmodics, antidepressants, and medications modifying bowel habit represent the main conventional IBS treatments. Unfortunately, most patients report long-term inadequacy of current drug therapy and a tendency to seek a variety of alternative remedies, especially of a dietary nature (up to 65 % of them attribute their symptoms to adverse food reactions) [4]. However, the relationship between IBS symptoms and diet is still controversial, because of research quality and low number of scientific studies [5]. This represents a glaring gap that needs to be addressed.

UR - http://hdl.handle.net/10447/180999

M3 - Chapter

SN - 978-3-319-30359-8

SP - 139

EP - 167

BT - Human Nutrition from the Gastroenterologist’s Perspective

ER -